We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
A majority of malignant tissues displayed weak to moderate cytoplasmic immunoreactivity. Strong positivity was observed in some tumors of the digestive system, breast, ovarium and lung.
A majority of colorectal, ovarian, thyroid, pancreatic, lung, cervical and gastric cancers displayed moderate to strong membranous and/or cytoplasmic staining. Remaining malignancies were generally negative.
Most malignant cells showed weak to moderate cytoplasmic immunoreactivity. Strong membranous positivity was for examples observed in a few pancreatic, ovarian and lung cancers. Several malignant lymphomas and renal cancers were negative.
This gene encodes a glycoprotein involved in the regulation of the complement cascade. Binding of the encoded protein to complement proteins accelerates their decay, thereby disrupting the cascade and preventing damage to host cells. Antigens present on this protein constitute the Cromer blood group system (CROM). Alternative splicing results in multiple transcript variants. The predominant transcript variant encodes a membrane-bound protein, but alternatively spliced transcripts may produce soluble proteins. [provided by RefSeq, Jul 2014]